NXC-201 CAR-T
NXC-201-AL-001
Phase 2 mab active
Quick answer
NXC-201 CAR-T for Light Chain (AL) Amyloidosis is a Phase 2 program (mab) at Immix Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Immix Biopharma
- Indication
- Light Chain (AL) Amyloidosis
- Phase
- Phase 2
- Modality
- mab
- Status
- active